Searchable abstracts of presentations at key conferences in endocrinology

ea0038p197 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Impact of number of transplanted human islet equivalents on successful return to normoglycaemia in an NSG diabetic mouse model

Bond Andrew , Noble June , Casey John , Campbell John , Forbes Shareen

Introduction: Islet transplantation (ITx) is a therapeutic option for patients with Type 1 diabetes. However there is attrition of graft function and the majority of patients require exogenous insulin injections and/or further transplants, within five years. Mouse models help elucidate mechanisms of islet graft failure and the NOD/Lt-scid IL2rγnull (NSG) mouse is useful to study human islet engraftment but few published studies exist. As diffe...

ea0021p88 | Clinical practice/governance and case reports | SFEBES2009

Phaeochromocytoma/paraganglionoma patients in a joint endocrine genetic clinic setting

Stewart Sue , Ayuk John , Campbell Chris , Cole Trevor

A 19-year-old student was referred with a history of increasing anxiety attacks, palpitations and breathlessness. Blood pressure and urinary catecholamine levels were elevated. MRI imaging confirmed a para-aortic paraganglionoma and MIBG scan highlighted bony metastases. The patient underwent surgery for the primary lesion and targeted MIBG therapy for metastases.Age of onset, malignant disease and metastases increase the likelihood of a genetic cause an...

ea0094oc4.3 | Reproductive Endocrinology | SFEBES2023

Self-administering post-cycle therapy is associated with biochemical gonadal recovery in men stopping anabolic-androgenic steroid use

Grant Bonnie , Campbell John , Pradeep Anjali , Burns Angela D. , Bassett Paul , Abbara Ali , Saket Priyadarshi , Minhas Sukhbinder , Dhillo Waljit S. , McVeigh James , Bhasin Shalender , Jayasena Channa N.

Background: Millions of men worldwide take anabolic-androgenic steroids (AAS) to boost muscle growth, but risk psychosis, cardiomyopathy, stroke and death. Users avoid stopping AAS because they are fearful of low testosterone symptoms including sexual dysfunction, depression and suicidality. To avoid these symptoms, men often illicitly self-medicate a 2–12-week course of drugs including selective oestrogen receptor modulators to boost testicular function ...